Advoro Zurich bolsters its partnership lineup with the promotion of former senior associate Thomas Nagel, a specialist in the fields of financial services, fintech, and financial market law. Here is a brief recap of his
Swiss building supplier Arbonia completed the sale of its climate division to Midea Electrics, a subsidiary of the Midea Group (Midea). Baker McKenzie Switzerland, in cooperation with other Baker McKenzie offices, advised the selling part,
Zurich-based fintech AMNIS completed a CHF 10 million series B financing round. Swisscom Ventures led the capital round in question, which saw the participation of existing investors – including co-investor Lansdowne. The operation also encompasses a CHF 2
Stefan Buerge (pictured) parts ways with Climeworks after more than five years. Amognst his most significant milestones, the first ever long-term carbon removal offtake agreements, financing rounds with the largest ever investments into direct air
Baker McKenzie advised the shareholders of Swiss fintech company EWM Global (EWM), on the sale of all shares in EWM to TMF Group (TMF), a globally active Dutch provider of compliance, admin and financial
Homburger advises Idorsia Ltd on its holistic restructuring, which includes the revision of its outstanding convertible bonds totaling CHF 800 million and the raising of CHF 150 million through a new money facility. The context In connection
Lenz & Staehelin advised South-Korean SK Telecom on all Swiss law aspects of its strategic partnership agreement with US-based quantum computing company, IonQ. The deal SK Telecom has agreed to transfer all its shares in
Swiss investment firm Nuavo completed its purchase of a majority stake Courgenay-based windows and doors manufacturer Domofen. Nexus Advocats advised the buyer throughout the operation, while Kellerhals Carrard represented the exiting shareholders. UBS took part
Switzerland’s immigration framework is set to undergo significant changes in 2025, affecting businesses, individuals, and legal practitioners alike. While certain updates bring more flexibility forspecific permit holders, others maintain the status quo on quotas and
Niederer Kraft Frey (NKF) advised AB2 Bio, a Swiss biotechnology company, on Swiss law matters in connection with the entry into an option and licensing agreement with Japanese pharmaceutical company Nippon Shinyaku. The context Headquartered
